Business context and reporting period
KBL Merger Corp. IV filed this unaudited Form 10-Q for the quarter and nine months ended September 30, 2017. The filing is for a blank-check company, not an operating business: it had not commenced operations and reported no operating revenue. It was seeking a business combination, with a stated focus on healthcare and related wellness. The filing identifies the registrant as KBL Merger Corp. IV; this differs from the request metadata name, FORUM MARKETS Inc, and should be verified.
Key financial metrics
| Metric | Three months ended September 30, 2017 | Nine months ended September 30, 2017 |
|---|---|---|
| Operating revenue | $0 | $0 |
| General and administrative expenses | $140,849 | $222,545 |
| Trust-account interest income | $333,905 | $389,634 |
| Income before income taxes | $193,056 | $167,089 |
| Income tax provision | $106,940 | $106,940 |
| Net income | $86,116 | $60,149 |
At September 30, 2017, total assets were $117.0 million, including $116.5 million in cash and marketable securities held in trust and $453,529 of cash outside the trust. Total liabilities were $4.3 million, including $4.025 million of deferred underwriting fees payable upon a completed business combination. Current liabilities were $239,037; there was no note payable outstanding. Common stock subject to possible redemption was classified outside stockholders’ equity at $107.8 million. Stockholders’ equity was $5.0 million.
Operating cash flow was negative $222,076 for the nine months. Financing activities provided $116.8 million and investing activities used $116.15 million, primarily reflecting the trust-account funding. No profit margin is meaningful for this pre-revenue company.
Material changes versus comparable periods
The company completed its IPO and private placement in June 2017, including full exercise of the underwriters’ over-allotment option. Gross proceeds were $120.025 million, and $116.15 million was placed in the trust account. The prior-year comparison covers only the period from inception on September 7, 2016 through September 30, 2016, when the company recorded a $683 loss; it is not a like-for-like operating comparison. Compared with December 31, 2016, trust assets and redemption-classified shares had been established, cash increased to $453,529, and total assets rose from $240,000 to $117.0 million.
Outlook, risks, and unusual items
- Management expected no operating revenue until after a business combination and anticipated ongoing public-company, target-search, due-diligence, and transaction costs.
- The company stated it did not expect to need additional funds for planned expenditures, but warned that cost overruns, insufficient acquisition financing, or substantial shareholder redemptions could require additional financing. A combination was not assured.
- The company had to complete a qualifying business combination within its defined combination period, stated as 18 months or 21 months “as applicable”; the filing text does not provide a clear applicable deadline here. Failure would trigger liquidation and redemption of public shares from the trust, subject to stated terms.
- Public shareholders could redeem shares for a pro rata share of trust assets, initially about $10.10 per share plus eligible interest. A 15% limit applies to redemption by an individual shareholder, affiliates, or group. The company must meet a $5,000,001 net tangible asset condition at closing.
- The trust was invested in cash and short-term U.S. Treasury securities. Management said the short duration limited material interest-rate exposure. Sponsor advances were non-interest-bearing and due on demand; $21,041 remained outstanding at quarter-end.
- Management reported effective disclosure controls and no material change in internal control over financial reporting during the quarter. The filing reported no legal proceedings and no material changes to prospectus risk factors.
Most important facts to verify
- Confirm the registrant identity: the filing is for KBL Merger Corp. IV, while the request metadata names FORUM MARKETS Inc.
- Verify the applicable combination-period deadline and any subsequent business-combination developments.
- Review trust balance, redemption provisions, and the deferred $4.025 million underwriting fee when assessing funds available to a transaction.
- Assess expected transaction and public-company costs against the $453,529 of cash held outside the trust and the potential need for additional financing.
- Check the filing’s prospectus risk factors and transaction terms, including potential dilution from warrants, rights, new equity, or debt.